nicotine has been researched along with pentoxifylline in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 9 (69.23) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Aker, JS; Colen, LB; Lewis, B; Mancoll, J | 1 |
| Calabrese, EJ | 1 |
| de Tolosa, EM; Mauad, RJ; Mauad, T; Shimizu, MH | 1 |
| Bastug, F; Bastug, O; Canoz, O; Gunes, I; Gunes, T; Koklu, E; Kula, M; Kurtoglu, S | 1 |
1 review(s) available for nicotine and pentoxifylline
| Article | Year |
|---|---|
Cell migration/chemotaxis: biphasic dose responses.
Topics: Alcohols; alpha 1-Antitrypsin; Animals; Cell Movement; Chemotaxis; Dose-Response Relationship, Drug; Fibroblasts; Ganglionic Stimulants; Humans; Mice; Neoplasms; Neoplastic Cells, Circulating; Nerve Growth Factor; Neutrophils; Nicotine; Pentoxifylline; Platelet Aggregation Inhibitors; Platelet-Derived Growth Factor | 2001 |
12 other study(ies) available for nicotine and pentoxifylline
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effect of pentoxifylline on random-pattern skin-flap necrosis induced by nicotine treatment in the rat.
Topics: Analysis of Variance; Animals; Erythrocyte Deformability; Graft Survival; Necrosis; Nicotine; Nicotinic Agonists; Pentoxifylline; Preoperative Care; Random Allocation; Rats; Rats, Sprague-Dawley; Surgical Flaps; Time Factors; Vasodilator Agents | 1997 |
Buflomedil and pentoxifylline in the viability of dorsal cutaneous flaps of rats treated with nicotine.
Topics: Animals; Drug Combinations; Graft Survival; Male; Microcirculation; Nicotine; Pentoxifylline; Pyrrolidines; Rats; Rats, Wistar; Skin Transplantation; Smoking; Surgical Flaps; Vasodilator Agents | 2006 |
Influence of maternal nicotine exposure on neonatal rat bone: protective effect of pentoxifylline.
Topics: Animals; Animals, Newborn; Animals, Suckling; Apoptosis; Birth Weight; Body Weight; Bone and Bones; Bone Density; Bone Development; Chondrocytes; Female; Femur; Litter Size; Male; Maternal Exposure; Nicotine; Pentoxifylline; Pregnancy; Rats; Rats, Sprague-Dawley; Sex Factors | 2007 |